Lixisenatide structure
|
Common Name | Lixisenatide | ||
---|---|---|---|---|
CAS Number | 320367-13-3 | Molecular Weight | 4858.49000 | |
Density | N/A | Boiling Point | N/A | |
Molecular Formula | C215H347N61O65S | Melting Point | N/A | |
MSDS | N/A | Flash Point | N/A |
Use of LixisenatideLixisenatide is a glucagon-like peptide-1 (GLP-1) receptor agonist that can be used in the treatment of type 2 diabetes mellitus (T2DM). Sequence: His-Gly-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Leu-Ser-Lys-Gln-Met-Glu-Glu-Glu-Ala-Val-Arg-Leu-Phe-Ile-Glu-Trp-Leu-Lys-Asn-Gly-Gly-Pro-Ser-Ser-Gly-Ala-Pro-Pro-Ser-Lys-Lys-Lys-Lys-Lys-Lys-NH2. |
Name | lixisenatide |
---|---|
Synonym | More Synonyms |
Description | Lixisenatide is a glucagon-like peptide-1 (GLP-1) receptor agonist that can be used in the treatment of type 2 diabetes mellitus (T2DM). Sequence: His-Gly-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Leu-Ser-Lys-Gln-Met-Glu-Glu-Glu-Ala-Val-Arg-Leu-Phe-Ile-Glu-Trp-Leu-Lys-Asn-Gly-Gly-Pro-Ser-Ser-Gly-Ala-Pro-Pro-Ser-Lys-Lys-Lys-Lys-Lys-Lys-NH2. |
---|---|
Related Catalog | |
Target |
GLP-1 receptor[1][2]. |
References |
Molecular Formula | C215H347N61O65S |
---|---|
Molecular Weight | 4858.49000 |
Exact Mass | 4855.54000 |
PSA | 2085.46000 |
LogP | 2.13170 |
Storage condition | -20°C |
ZP 10 |
AVE 0010 |
ZP10A peptide |
lixisenatide |
des-38-proline-exendine-4 (Heloderma suspectum)-(1-39)- peptidylpenta-L-lysyl-L-lysinamide |
AVE0010 |
Lyxumia |
UNII-74O62BB01U |